Page last updated: 2024-08-23

zidovudine and Familial Spastic Paraparesis, Htlv-1-Associated

zidovudine has been researched along with Familial Spastic Paraparesis, Htlv-1-Associated in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (40.00)	18.2507
2000's	2 (20.00)	29.6817
2010's	3 (30.00)	24.3611
2020's	1 (10.00)	2.80

Authors

Authors	Studies
Casseb, J; Eslami, M; Ghazvini, K; Karbalaei, M; Keikha, M; Yousefi, B; Yousefi, M	1
Gállego Pérez-Larraya, J; Martín, P; Moreno-Ajona, D; Yuste, JR	1
Amer, S; Hassan, S; Zervos, M	1
Gessain, A; Mahieux, R	1
Afonso, PV; Bangham, CR; Dubreuil, G; Estaquier, J; Gessain, A; Hermine, O; Mahieux, R; Mekaouche, M; Moriceau, A; Mortreux, F; Plumelle, Y; Toulza, F; Wattel, E	1
Babiker, A; Bangham, CR; Barfield, A; Furukawa, Y; Goon, P; Green, H; Mosley, A; Nose, H; Osame, M; Rudge, P; Taylor, GP; Usuku, K; Weber, JN	1
Benedict, D; DeFreitas, E; Sazant, A; Sheremata, WA; Squilacote, DC	1
Osame, M	1
Chan, G; Diagne, A; Harrington, W; Kacena, A; Rosenblatt, JD; Rosenthal, M; Saxton, E; Tomkins, P; Valderama, R; Zhao, JQ	1
Bolgert, F; de Thé, G; Gessain, A; Gout, O; Iba-Zizen, M; Kouzan, S; Lyon-Caen, O	1

Reviews

3 review(s) available for zidovudine and Familial Spastic Paraparesis, Htlv-1-Associated

Article	Year
Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection. Microbial pathogenesis, 2020, Volume: 144 Topics: Adult; Antigens, CD; Chronic Disease; CTLA-4 Antigen; Hepatitis A Virus Cellular Receptor 2; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukocytes, Mononuclear; Lymphocyte Activation Gene 3 Protein; Molecular Targeted Therapy; Paraparesis, Tropical Spastic; Programmed Cell Death 1 Receptor; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Receptors, Immunologic; Signal Transduction; Zidovudine	2020
Adult T-cell leukemia/lymphoma and HTLV-1. Current hematologic malignancy reports, 2007, Volume: 2, Issue:4 Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; CD4-Positive T-Lymphocytes; Clinical Trials as Topic; Daclizumab; Drug Resistance, Neoplasm; Endemic Diseases; Female; Gene Products, tax; Genes, pX; Human T-lymphotropic virus 1; Humans; Immunoglobulin G; Immunophenotyping; Immunotherapy; Infant, Newborn; Infectious Disease Transmission, Vertical; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Oxides; Paraparesis, Tropical Spastic; Pregnancy; Pregnancy Complications, Infectious; Zidovudine	2007
[HTLV-I-associated myelopathy]. Ryoikibetsu shokogun shirizu, 1999, Issue:24 Pt 2 Topics: Antiviral Agents; Diagnosis, Differential; Humans; Interferon-alpha; Paraparesis, Tropical Spastic; Plasmapheresis; Prednisolone; Prognosis; Zidovudine	1999

Trials

1 trial(s) available for zidovudine and Familial Spastic Paraparesis, Htlv-1-Associated

Article	Year
Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial. Retrovirology, 2006, Sep-19, Volume: 3 Topics: Aged; Anti-HIV Agents; Cell Proliferation; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamivudine; Male; Middle Aged; Paraparesis, Tropical Spastic; Placebos; Viral Load; Zidovudine	2006

Other Studies

6 other study(ies) available for zidovudine and Familial Spastic Paraparesis, Htlv-1-Associated

Article	Year
HTLV-1 myelopathy after renal transplant and antiviral prophylaxis: the need for screening. Journal of neurovirology, 2018, Volume: 24, Issue:4 Topics: Antiviral Agents; Female; Humans; Kidney Transplantation; Middle Aged; Paraparesis, Tropical Spastic; Raltegravir Potassium; Transplants; Zidovudine	2018
Tropical spastic paraparesis treated with Combivir (lamivudine-zidovudine). Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2013, Volume: 20, Issue:5 Topics: Aged; Drug Combinations; Female; Human T-lymphotropic virus 1; Humans; Lamivudine; Paraparesis, Tropical Spastic; Severity of Illness Index; Treatment Outcome; Zidovudine	2013
Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood, 2010, Nov-11, Volume: 116, Issue:19 Topics: Animals; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD8-Positive T-Lymphocytes; Deltaretrovirus Infections; Disease Models, Animal; Drug Therapy, Combination; Female; Histone Deacetylase Inhibitors; HTLV-I Infections; Humans; Male; Monkey Diseases; Papio; Paraparesis, Tropical Spastic; Reverse Transcriptase Inhibitors; Simian T-lymphotropic virus 1; T-Lymphocyte Subsets; Valproic Acid; Viral Load; Zidovudine	2010
High-dose zidovudine induction in HTLV-I-associated myelopathy: safety and possible efficacy. Neurology, 1993, Volume: 43, Issue:10 Topics: Adult; Anxiety; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gastrointestinal Diseases; Headache; Humans; Male; Middle Aged; Paraparesis, Tropical Spastic; Remission Induction; Safety; Sleep Initiation and Maintenance Disorders; Zidovudine	1993
Progressive spastic myelopathy in a patient co-infected with HIV-1 and HTLV-II: autoantibodies to the human homologue of rig in blood and cerebrospinal fluid. AIDS (London, England), 1992, Volume: 6, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Amino Acid Sequence; Autoantibodies; Brain Chemistry; Cloning, Molecular; HTLV-II Infections; Humans; Middle Aged; Molecular Sequence Data; Nuclear Proteins; Paraparesis, Tropical Spastic; Proviruses; Zidovudine	1992
The effect of zidovudine on chronic myelopathy associated with HTLV-1. Journal of neurology, 1991, Volume: 238, Issue:2 Topics: Humans; Paraparesis, Tropical Spastic; Prognosis; Prospective Studies; Zidovudine	1991